With the symbol of SGEN, Seattle Genetics will be the first stock pick for the up coming workshop. Today it traded at $11.73 and if it can trade down to the $11.00 to $11.25 area we will look for a "Base System" buy trigger.
Seattle Genetics, Inc. (Nasdaq:SGEN) announced on July 31, 2008 that it has initiated a phase I clinical trial of SGN-70, a humanized monoclonal antibody targeting CD70 that is being developed as an investigational therapy for autoimmune diseases. The trial will assess the safety, tolerability and pharmacokinetics of SGN-70 in healthy volunteers. CD70 is also expressed on several types of cancer, including multiple myeloma, lymphoma, renal cell cancer, glioblastoma and several other solid tumors. In addition to SGN-70, Seattle Genetics is advancing SGN-75, an antibody-drug conjugate targeting CD70, for the treatment of cancer and expects to file an investigational new drug (IND) application in 2009.
Now of course, only a fool would just buy this because you read something on the internet or in a blog about it. But follow along over the next several weeks as we move toward the workshop. I want to make sure that you know that these picks are not in hindsight...cherry pickin...crapola. At this workshop, I will show how I find these picks, how I determine which ones could be used for a trade, how I setup the trade and then how I trigger into the trade....also what am I looking for in profits......
This workshop is for anyone that wants to understand how to trade without depending upon your barber, the paperboy, mother-in-law or for heaven sake......MARIA.....:)
No comments:
Post a Comment